Fri, Nov 20, 2026中文About
Filings today 284 / Covered 15
Source: TDnet timely disclosures
Updated 11/20 20:30M&A / TOB 20 Guidance 7 Buybacks 11 Dividends 4 Capital 12 Earnings 16 People 3

Altplus Holdings to sell 23 million shares at ¥3, issue new warrants and bonds

Thu, Nov 12, 2026 17:45 JST Altplus Holdings (3672.T) Information & Communication 中文

Altplus Holdings (3672), a game company listed on the Tokyo Stock Exchange's Standard market, said on Nov. 12 it will issue 23 million new shares at ¥3 each to Jiietto Co. and sell three series of warrants exercisable at ¥3 along with its first unsecured straight bonds, subject to shareholder approval on Dec. 24.

New share issue price¥3 per share
New shares issued23 million shares
13th-series warrant shares154.5 million shares
Shareholders' meetingDec. 24, 2026

The 13th- and 14th-series warrants will go to G Future Fund No. 1 Investment Limited Partnership (G Fund), and the 15th series and the bonds to EVO FUND. Exercise prices are fixed, and proceeds from the 15th series will first be used to redeem the bonds early. G Fund generally cannot exercise the 13th series before the bonds are redeemed, nor the 14th while EVO FUND holds them. Warrant proceeds below assume full exercise.

ItemSharesProceeds
New shares (Jiietto)23 million¥69 million
13th warrants (G Fund)154.5 million¥463.5 million
14th warrants (G Fund)38 million¥114.0 million
15th warrants (EVO FUND)80 million¥240.0 million

Altplus will also acquire and cancel the remaining 548,120 units of its 11th-series warrants and the 920,000 12th-series units held by G Fund; 380,000 12th-series units held by Representative Director Takeshi Ishii and another individual are excluded. The two series were meant to raise about ¥11.1 billion for M&A and a new crypto-asset business, but exercises stalled as the stock often traded below the 11th series' ¥30 minimum exercise price, and the 12th series drew none even after its price was cut to ¥30 from ¥54. Net proceeds to date total ¥612 million.

In the year ended September 2026, consolidated sales fell 11.4% to ¥2,568 million and the net loss attributable to owners of the parent was ¥1,281 million, a 13th straight period of losses. Cash and equivalents stood at ¥645 million, and the company said events or conditions exist that raise significant doubt about its ability to continue as a going concern.

The issuance requires approval at the Dec. 24 shareholders' meeting of proposals including the favorable-price issue, large-scale dilution and an increase in authorized shares. Payment and allotment are set for Dec. 25. The 13th and 15th series become exercisable on Dec. 28, through Dec. 28, 2029 and Dec. 29, 2028, respectively, while the 14th series runs from Jan. 1, 2028 to Jan. 6, 2031.


Original filings
Related